Funding LM-Bs work was supported by an NHMRC Investigator grant (#1194698) and AMs work was supported by an NHMRC postgraduate scholarship (#1168623) and Queensland Health New Technology and Evaluation Fund (QCOS32950)
Doing glp-1 alone isn't dangerous but it's the version that tends to produce disappointing long-term outcomes, because the medication does its job and everything around it is left to chance
A well-validated nano-liquid chromatography-tandem mass spectrometry method, 156 which has limits of quantification for Ang fragments in the low pM range, failed to detect Ang A in the plasma of rats, suggesting that the endogenous plasma levels of Ang A in rats are very low compared with plasma concentrations of Ang II
PubMed Systematic reviewGLP-1 class evidence2025 Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition Supports body-composition, lean-mass, and metabolic-risk context
translated for a 250-pound individual, this could mean shedding 37 to 50 pounds